Patent AT-E401319-T1: [Translated] SUBSTITUTED 2-(2,6-DIOXOPIPERIDINE-3-YL)-PHTHALIMIDES AND METHOD FOR REDUCING TNF-ALPHA LEVELS
1. A 2,6-dioxopiperidine selected from the group consisting of n( a ) a compound of the formula: nin which: none of X and Y is C=O and the other of X and Y n( i ) each of R 1 , R 2 , R 3 , and R 4 , independently of yl of 1 to 4 carbon atoms, or alkoxy of 1 to 4 carbon atoms or ( ii ) one of R 1 , R 2 , R 3 , and R 4 is -NHR 5 and the remaining of R 1 , R 2 , R 3 , and R 4 are hydrogen; nR 5 is hydrogen, alkyl of 1 to 8 carbon atoms, or CO-R 7 -CH(R 10 )NR 8 R 9 ; nR 6 is hydrogen, alkyl of 1 to 8 carbon atoms, benzo, chloro, or fluoro; nR 7 is m -phenylene or p -phenylene or -(C n H 2 n )- in which n has a value of 0 to 4; each of R 8 and R 9 taken independently of the other is hydrogen or alkyl of 1 to 8 carbon atoms, or R 8 and R 9 taken together are tetramethylene, pentamethylene, hexamethylene, or -CH 2 CH 2 XCH 2 CH 2 - in which X is -O-, -S- or -NH-; nR 10 is hydrogen, alkyl of 1 to 8 carbon atoms, or phenyl; and n( b ) the acid addition salts of said compounds which contain a nitrogen atom capable of being protonated.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[
"009:25"
]
|
| contactPoint |
{
"fn": "NIH/NCBI Data Team",
"@type": "vcard:Contact",
"hasEmail": "mailto:info@ncbi.nlm.nih.gov"
}
|
| description | 1. A 2,6-dioxopiperidine selected from the group consisting of n( a ) a compound of the formula: nin which: none of X and Y is C=O and the other of X and Y n( i ) each of R 1 , R 2 , R 3 , and R 4 , independently of yl of 1 to 4 carbon atoms, or alkoxy of 1 to 4 carbon atoms or ( ii ) one of R 1 , R 2 , R 3 , and R 4 is -NHR 5 and the remaining of R 1 , R 2 , R 3 , and R 4 are hydrogen; nR 5 is hydrogen, alkyl of 1 to 8 carbon atoms, or CO-R 7 -CH(R 10 )NR 8 R 9 ; nR 6 is hydrogen, alkyl of 1 to 8 carbon atoms, benzo, chloro, or fluoro; nR 7 is m -phenylene or p -phenylene or -(C n H 2 n )- in which n has a value of 0 to 4; each of R 8 and R 9 taken independently of the other is hydrogen or alkyl of 1 to 8 carbon atoms, or R 8 and R 9 taken together are tetramethylene, pentamethylene, hexamethylene, or -CH 2 CH 2 XCH 2 CH 2 - in which X is -O-, -S- or -NH-; nR 10 is hydrogen, alkyl of 1 to 8 carbon atoms, or phenyl; and n( b ) the acid addition salts of said compounds which contain a nitrogen atom capable of being protonated. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Official Data Source",
"mediaType": "text/html",
"description": "Access the complete Patent AT-E401319-T1: [Translated] SUBSTITUTED 2-(2,6-DIOXOPIPERIDINE-3-YL)-PHTHALIMIDES AND METHOD FOR REDUCING TNF-ALPHA LEVELS on the official website.",
"downloadURL": "https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401319-T1"
}
]
|
| identifier | https://healthdata.gov/api/views/c5i7-muj7 |
| issued | 2025-09-05 |
| keyword |
[
"chemistry",
"innovation",
"patent",
"pubchem",
"research"
]
|
| landingPage | https://healthdata.gov/d/c5i7-muj7 |
| modified | 2025-09-06 |
| programCode |
[
"009:066"
]
|
| publisher |
{
"name": "National Center for Biotechnology Information (NCBI)",
"@type": "org:Organization"
}
|
| theme |
[
"NIH"
]
|
| title | Patent AT-E401319-T1: [Translated] SUBSTITUTED 2-(2,6-DIOXOPIPERIDINE-3-YL)-PHTHALIMIDES AND METHOD FOR REDUCING TNF-ALPHA LEVELS |
